sk-11139

N/A

Report date: 2025/01/26 17:52:03
NME

Base Information

Drug Namesk-11139
Drug Alias Namelipogenesis pathway inhibitors (Stanford University School of Medicine)sk-11139
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid metabolism inhibitors
TargetsUpdating
Therapy Area/IndicationsKidney Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStanford University School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesStanford University School of Medicine
Inactive CompaniesN/A
Active IndicationsKidney Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A